Michael Ujiki to Pancreatic Neoplasms
This is a "connection" page, showing publications Michael Ujiki has written about Pancreatic Neoplasms.
Connection Strength
1.025
-
Guidelines for the surgical management of pancreatic adenocarcinoma. Semin Oncol. 2007 Aug; 34(4):311-20.
Score: 0.205
-
A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest. Biochem Biophys Res Commun. 2006 Feb 24; 340(4):1224-8.
Score: 0.184
-
Surgical management of pancreatic cancer. Semin Radiat Oncol. 2005 Oct; 15(4):218-25.
Score: 0.180
-
Anti-pancreatic cancer effects of a polar extract from the edible sea cucumber, Cucumaria frondosa. Pancreas. 2010 Jul; 39(5):646-52.
Score: 0.063
-
Sansalvamide induces pancreatic cancer growth arrest through changes in the cell cycle. Anticancer Res. 2010 Jan; 30(1):73-8.
Score: 0.061
-
Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines. Mol Carcinog. 2008 Nov; 47(11):835-44.
Score: 0.056
-
Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Surgery. 2007 Oct; 142(4):529-34; discussion 534-7.
Score: 0.052
-
Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res. 2007 Apr; 138(2):163-9.
Score: 0.049
-
Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs. Mol Cancer. 2005 Aug 05; 4:27.
Score: 0.045
-
On the potential use of flavonoids in the treatment and prevention of pancreatic cancer. In Vivo. 2005 Jan-Feb; 19(1):61-7.
Score: 0.043
-
Pancreatic cancer stimulates pancreatic stellate cell proliferation and TIMP-1 production through the MAP kinase pathway. Biochem Biophys Res Commun. 2004 Oct 29; 323(4):1241-5.
Score: 0.042
-
Adding days spent in readmission to the initial postoperative length of stay limits the perceived benefit of laparoscopic distal pancreatectomy when compared with open distal pancreatectomy. Am J Surg. 2011 Mar; 201(3):295-9; discussion 299-300.
Score: 0.016
-
A prospective single institution comparison of peri-operative outcomes for laparoscopic and open distal pancreatectomy. Surgery. 2009 Oct; 146(4):635-43; discussion 643-5.
Score: 0.015
-
The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells. Pancreas. 2009 May; 38(4):409-15.
Score: 0.014